ERG and prostate carcinoma: Consistent with these, in a tissue reconstitution model, lentiviral overexpression of ERG (or ETV1) in prostate cells collaborates with activation of the PI3K pathway or the androgen receptor (AR) pathway to induce distinct prostate carcinomas [11].